Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer's disease and related dementias
Background Alzheimer's disease and related dementias (ADRD) affect over 55 million
globally. Current clinical trials suffer from low recruitment rates, a challenge potentially …
globally. Current clinical trials suffer from low recruitment rates, a challenge potentially …
[图书][B] Improving Eligibility Prescreening for Alzheimer's Disease and Related Dementias Clinical Trials with Natural Language Processing
BRS Idnay - 2022 - search.proquest.com
Alzheimer's disease and related dementias (ADRD) are among the leading causes of
disability and mortality among the older population worldwide and a costly public health …
disability and mortality among the older population worldwide and a costly public health …